23 February 2018
News and Views
Links and Services
The recent Alimentary Pharmacology & Therapeutics examined the efficacy and safety of thalidomide for inducing, and maintaining remission in Crohn's disease and ulcerative colitis.
It has been reported that thalidomide may be effective in treating inflammatory bowel disease (IB
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors